KEY FEATURES
| Full Name | Interferon Regulatory Factor 3 |
|---|---|
| Synonym | IRF3 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human IRF3 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human IRF3. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human IRF3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human IRF3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human IRF3. You can calculate the concentration of Human IRF3 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human IRF3 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.55 | 1.14 | 3.9 | 0.58 | 1.1 | 3.63 |
| Standard deviation | 0.03 | 0.06 | 0.15 | 0.04 | 0.06 | 0.13 |
| CV(%) | 5.12 | 4.85 | 3.83 | 6.35 | 5.09 | 3.6 |
RECOVERY
The recovery of Human IRF3 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 94-106 | 100 |
| EDTA plasma (n=8) | 85-97 | 91 |
| Cell culture media (n=8) | 87-101 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human IRF3 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with IRF3 ELISA Kits
| TBK1 ELISA Kit | publications with IRF3 and TBK1 |
| JUN ELISA Kit | publications with IRF3 and JUN |
| MAVS ELISA Kit | publications with IRF3 and MAVS |
| IRF5 ELISA Kit | publications with IRF3 and IRF5 |
| IKBKE ELISA Kit | publications with IRF3 and IKBKE |
| IFNB1 ELISA Kit | publications with IRF3 and IFNB1 |
| CREBBP ELISA Kit | publications with IRF3 and CREBBP |
| PIN1 ELISA Kit | publications with IRF3 and PIN1 |
| EP300 ELISA Kit | publications with IRF3 and EP300 |
Pathways associated with IRF3 ELISA Kit
| Activated TLR4 Signalling Pathway | Activated TLR4 Signalling Pathway |
| Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon Pathway | Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon Pathway |
| Antiviral Mechanism By IFN-stimulated Genes Pathway | Antiviral Mechanism By IFN-stimulated Genes Pathway |
| Apoptosis Pathway | Apoptosis Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| Cytosolic DNA-sensing Pathway | Cytosolic DNA-sensing Pathway |
| Cytosolic Sensors Of Pathogen-associated DNA Pathway | Cytosolic Sensors Of Pathogen-associated DNA Pathway |
| Epstein-Barr Virus Infection Pathway | Epstein-Barr Virus Infection Pathway |
Diseases associated with IRF3 ELISA Kit
| Inflammation | publications with IRF3 and Inflammation |
| Necrosis | publications with IRF3 and Necrosis |
| Death | publications with IRF3 and Death |
| Liver Diseases | publications with IRF3 and Liver Diseases |
| Cardiovascular Diseases | publications with IRF3 and Cardiovascular Diseases |
| Kidney Diseases | publications with IRF3 and Kidney Diseases |
| Carcinoma | publications with IRF3 and Carcinoma |
| Atherosclerosis | publications with IRF3 and Atherosclerosis |
| Neoplasms, Experimental | publications with IRF3 and Neoplasms, Experimental |
| Cell Transformation, Neoplastic | publications with IRF3 and Cell Transformation, Neoplastic |
Organs/Tissues associated with IRF3 ELISA Kit
| Blood | publications with IRF3 and Blood |
| Liver | publications with IRF3 and Liver |
| Bone | publications with IRF3 and Bone |
| Kidney | publications with IRF3 and Kidney |
| Lung | publications with IRF3 and Lung |
| Brain | publications with IRF3 and Brain |
| Skin | publications with IRF3 and Skin |
| Spleen | publications with IRF3 and Spleen |
| Muscle | publications with IRF3 and Muscle |
| Heart | publications with IRF3 and Heart |